SANTINI, Daria
 Distribuzione geografica
Continente #
EU - Europa 15
NA - Nord America 10
AS - Asia 1
Totale 26
Nazione #
IT - Italia 12
US - Stati Uniti d'America 10
CZ - Repubblica Ceca 1
FR - Francia 1
GB - Regno Unito 1
TH - Thailandia 1
Totale 26
Città #
Rome 3
Chicago 2
Ashburn 1
Barnet 1
Boardman 1
Buffalo 1
Crugers 1
Houston 1
Kansas City 1
Samut Prakan 1
Seattle 1
Villeneuve-le-roi 1
Totale 15
Nome #
New oral anticoagulants in non-valvular atrial fibrillation., file e3835311-caec-15e8-e053-a505fe0a3de9 10
Determinants of peak oxygen uptake in patients with hypertrophic cardiomyopathy: a single-center study, file e3835312-221d-15e8-e053-a505fe0a3de9 4
Prognostic implications of defibrillation threshold testing in patients with hypertrophic cardiomyopathy, file e3835316-04c4-15e8-e053-a505fe0a3de9 4
Eligibility for the subcutaneous implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy, file e3835312-ccb6-15e8-e053-a505fe0a3de9 3
Clinical Impact of Nonsustained Ventricular Tachycardia Recorded by the Implantable Cardioverter-Defibrillator in Patients with Hypertrophic Cardiomyopathy., file e3835313-0093-15e8-e053-a505fe0a3de9 2
Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients, file 44ca4451-1e94-4699-ae31-35e8a576ac2a 1
Osteopontin and Galectin-3 Predict the Risk of Ventricular Tachycardia and Fibrillation in Heart Failure Patients with Implantable Defibrillators., file e3835312-5a50-15e8-e053-a505fe0a3de9 1
Prognostic implications of defibrillation threshold testing in patients with hypertrophic cardiomyopathy, file e383531b-f61e-15e8-e053-a505fe0a3de9 1
Totale 26
Categoria #
all - tutte 55
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 1 0 0
2022/202314 0 2 2 2 0 2 2 3 1 0 0 0
Totale 26